Market revenue in 2022 | USD 1,029.6 million |
Market revenue in 2030 | USD 818.3 million |
Growth rate | -2.8% (CAGR from 2022 to 2030) |
Largest segment | Nasopharyngeal (np) swab |
Fastest growing segment | Oropharyngeal (OP) swab |
Historical data covered | 2020 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nasopharyngeal (NP) swab, Oropharyngeal (OP) swab, Nasal Swabs, Saliva |
Key market players worldwide | Abbott Laboratories, Mylab Discovery Solutions, Converge Technology Solutions Corp, Thermo Fisher Scientific Inc, Roche, Danaher Corp, Birks Group Inc Class A, Cue Health Inc, Quest Diagnostics Inc, SD Biosensor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 detection poc kits market will help companies and investors design strategic landscapes.
Nasopharyngeal (np) swab was the largest segment with a revenue share of 57.55% in 2022. Horizon Databook has segmented the North America covid-19 detection poc kits market based on nasopharyngeal (np) swab, oropharyngeal (op) swab, nasal swabs, saliva covering the revenue growth of each sub-segment from 2020 to 2030.
The spike in incidence of COVID-19 and local presence of major players involved in research & manufacture of diagnostic tests, utilizing various technologies, are expected to contribute to the North American market's growth.
As reported by World meter, as of June 2021, the number of COVID-19 cases in North America reached 40,032,365, indicating the increased demand for COVID-19 diagnostic kits in the region. Due to the pandemic, governing bodies such as Health Canada and the U.S.
FDA allowed Emergency Use Authorizations (EUAs) for COVID-19 test kits, including PoC tests, to increase testing. For instance, in September 2021, the U.S. FDA authorized over 400 COVID-19 tests and collection kits, including 235 molecular, 88 antibody, and 34 antigen tests.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America covid-19 detection poc kits market , including forecasts for subscribers. This continent databook contains high-level insights into North America covid-19 detection poc kits market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account